154 related articles for article (PubMed ID: 14513290)
1. Dynamics of circulating t(14;18)-positive cells during first-line and subsequent lines of treatment in follicular lymphoma.
Mandigers CM; Meijerink JP; van 't Veer MB; Mensink EJ; Raemaekers JM
Ann Hematol; 2003 Dec; 82(12):743-9. PubMed ID: 14513290
[TBL] [Abstract][Full Text] [Related]
2. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
[TBL] [Abstract][Full Text] [Related]
3. Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation.
Hirt C; Dölken G
Bone Marrow Transplant; 2000 Feb; 25(4):419-26. PubMed ID: 10723586
[TBL] [Abstract][Full Text] [Related]
4. LightCycler-based quantitative real-time PCR monitoring of patients with follicular lymphoma receiving rituximab in combination with conventional or high-dose cytotoxic chemotherapy.
Martin S; Fischer C; Free M; Kurreck B; Stockinger H; Fenk R; Arnold C; Kliszewski S; Meckenstock G; Haas R; Kronenwett R
Eur J Haematol; 2005 Apr; 74(4):282-92. PubMed ID: 15777339
[TBL] [Abstract][Full Text] [Related]
5. One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?
Schmitt C; Grundt A; Buchholtz C; Scheuer L; Benner A; Hensel M; Ho AD; Leo E
Leuk Res; 2006 Dec; 30(12):1563-8. PubMed ID: 16530831
[TBL] [Abstract][Full Text] [Related]
6. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
7. [Practical aspects and clinical value of t(14;18) monitoring in peripheral blood of the follicular lymphoma patients].
Janíková-Oborilová A; Mayer J; Dvorákova D; Mejstrík P; Navritíl M; Vásová I; Kren L; Matuska M
Cas Lek Cesk; 2007; 146(4):374-81; discussion 381-2. PubMed ID: 17491248
[TBL] [Abstract][Full Text] [Related]
8. Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients.
Hirt C; Schüler F; Kiefer T; Schwenke C; Haas A; Niederwieser D; Neser S; Assmann M; Srock S; Rohrberg R; Dachselt K; Leithäuser M; Rabkin CS; Herold M; Dölken G
Br J Haematol; 2008 May; 141(5):631-40. PubMed ID: 18422779
[TBL] [Abstract][Full Text] [Related]
9. [Minimal residual disease in follicular and mantle cell lymphoma. Detection using quantitative molecular monitoring of circulating lymphoma cells].
Schüler F; Hirt C; Dölken L; Krüger W; Dölken G
Dtsch Med Wochenschr; 2005 Sep; 130(38):2130-4. PubMed ID: 16172952
[TBL] [Abstract][Full Text] [Related]
10. Evolution of BCL-2/IgH hybrid gene RNA expression during treatment of T(14;18)-bearing follicular lymphomas.
Soubeyran P; Hostein I; Debled M; Eghbali H; Soubeyran I; Bonichon F; Astier-Gin T; Hoerni B
Br J Cancer; 1999 Nov; 81(5):860-9. PubMed ID: 10555759
[TBL] [Abstract][Full Text] [Related]
11. [Achieving Bcl-2/IgH negativity in peripheral blood/bone marrow after therapy implies better prognosis for patients with follicular lymphoma].
Belada D; Smolej L; Stepánková P; Beránek M; Dvoráková D; Bukac J; Malý J
Vnitr Lek; 2007 Oct; 53(10):1057-63. PubMed ID: 18072430
[TBL] [Abstract][Full Text] [Related]
12. The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells.
McGregor DK; Keever-Taylor CA; Bredeson C; Schur B; Vesole DH; Logan B; Chang CC
Bone Marrow Transplant; 2005 Jun; 35(11):1049-54. PubMed ID: 15821762
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of real-time PCR in long-term follow-up of follicular lymphoma patients.
Tysarowski A; Fabisiewicz A; Paszkiewicz-Kozik E; Kulik J; Walewski J; Siedlecki JA
Acta Biochim Pol; 2007; 54(1):135-42. PubMed ID: 17351675
[TBL] [Abstract][Full Text] [Related]
14. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
[TBL] [Abstract][Full Text] [Related]
15. Use of the polymerase chain reaction and direct sequencing analysis to detect cells with the t(14;18) in autologous bone marrow from patients with follicular lymphoma, before and after in vitro treatment.
Pappa VI; Wilkes S; Salam A; Young BD; Lister TA; Rohatiner AZ
Bone Marrow Transplant; 1998 Sep; 22(6):553-8. PubMed ID: 9758342
[TBL] [Abstract][Full Text] [Related]
16. Semiquantitative polymerase chain reaction for t(14;18) in follicular lymphomas: a colorimetric approach.
Deggerdal AH; Pettersen F; Kvalheim G; Hornes E; Smeland E; Fodstad O; Hovig E
Lab Invest; 1995 Apr; 72(4):411-8. PubMed ID: 7723279
[TBL] [Abstract][Full Text] [Related]
17. [Detection and diagnostic value of t(14;18) translocation in minimal residual disease of follicular lymphoma].
Bessenyei B; Urbán L; Takács I; Zeher M; Szegedi G; Semsei I
Orv Hetil; 2000 Jul; 141(31):1715-9. PubMed ID: 10976195
[TBL] [Abstract][Full Text] [Related]
18. Sensitive and reproducible detection of occult disease in patients with follicular lymphoma by PCR amplification of t(14;18) both pre- and post-treatment.
Berinstein NL; Jamal HH; Kuzniar B; Klock RJ; Reis MD
Leukemia; 1993 Jan; 7(1):113-9. PubMed ID: 8418370
[TBL] [Abstract][Full Text] [Related]
19. Detection and quantification of MBR/JH2 t(14;18) BCL-2 gene rearrangement in follicular lymphoma using a combined real-time polymerase chain reaction assay.
Csernák E; Tóth E; Melegh Z; Schneider T; Rosta A; Szentirmay Z
Haematologica; 2006 Jun; 91(6):858-9. PubMed ID: 16704964
[TBL] [Abstract][Full Text] [Related]
20. Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution.
d'Amore F; Chan E; Iqbal J; Geng H; Young K; Xiao L; Hess MM; Sanger WG; Smith L; Wiuf C; Hagberg O; Fu K; Chan WC; Dave BJ
Clin Cancer Res; 2008 Nov; 14(22):7180-7. PubMed ID: 19010834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
